Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Ding

Showing results (431-440 of 453) with videos related to

Pageof 46
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 20, 2009
Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastomaH Zheng, H Ying, H Yan, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal AngiogenesisChudi O Ndubaku, Terry D Crawford, Huifen Chen, et al.
Journal of Medicinal Chemistry|October 6, 2000
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activityJ T Hunt, C Z Ding, R Batorsky, et al.
Journal of Medicinal Chemistry|December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferaseC Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry|December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferaseC Z Ding, R Batorsky, R Bhide, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Pageof 46

Showing results (431-440 of 453) with videos related to

Sort By:
Pageof 46
Cold Spring Harbor Symposia on Quantitative Biology|January 20, 2009
Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastomaH Zheng, H Ying, H Yan, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal AngiogenesisChudi O Ndubaku, Terry D Crawford, Huifen Chen, et al.
Journal of Medicinal Chemistry|October 6, 2000
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activityJ T Hunt, C Z Ding, R Batorsky, et al.
Journal of Medicinal Chemistry|December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferaseC Z Ding, R Batorsky, R Bhide, et al.
Journal of Medicinal Chemistry|December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferaseC Z Ding, R Batorsky, R Bhide, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2013
Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenasePeter S Dragovich, Benjamin P Fauber, Laura B Corson, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2010
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 proteaseCharles Z Ding, Yong-Kang Zhang, Xianfeng Li, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 proteaseXianfeng Li, Yong-Kang Zhang, Yang Liu, et al.
Journal of Medicinal Chemistry|April 5, 2012
Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutantsWieslaw M Kazmierski, Robert Hamatake, Maosheng Duan, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsXianfeng Li, Yang Liu, Yong-Kang Zhang, et al.
Pageof 46